Back to top
CLOSE

OUR
DOCTORS
OUR
LOCATIONS

Christopher Aderman, M.D.


David Aderman, M.D.

About me:

Areas of Expertise:

  • Macular Degeneration
  • Retinal Disease

Locations

Gresham  | (503) 255-2291
Barnes Road  | (503) 227-2020

Retina Specialist, Vitreoretinal Surgery
Board Certified, American Board of Ophthalmology

Dr. Christopher Aderman is originally from Maine and completed his undergraduate studies in biochemistry at Bowdoin College, graduating magna cum laude.  He went on to study retinal disease in a lab in Boston before attending Harvard Medical school where he received his M.D. degree.  He completed his medical internship at Beth Israel Deaconess Medical Center and Harvard Medical School and his ophthalmology residency at University of California, San Francisco.  During residency he was awarded a Heed Fellowship and was one of 5 ophthalmology residents in the country to be elected to the Society of Heed Fellows.

Dr. Aderman went on to complete his vitreoretinal surgery training at Wills Eye Hospital in Philadelphia, and he was one of 4 retina fellows in the county to receive a Ron Michels Foundation Fellowship Award.  He has published numerous articles in high impact peer reviewed journals and has served as an investigator on many clinical trials.  Dr. Aderman is a board certified ophthalmologist and is an active member of the American Academy of Ophthalmology, The Association for Research in Vision and Ophthalmology, and The American Society of Retinal Specialists.

 In his spare time, Dr. Aderman enjoys hiking, cycling, skiing, and golfing.




 

Education:

2016 - 2018 Fellow in Vitreoretinal Surgery - Wills Eye Hospital, Philadelphia, PA
2013 - 2016 Resident in Ophthalmology
University of California, San Francisco, CA
2012 - 2013 Intern in Medicine
Beth Israel Deaconess Medical Center, Boston, MA
2008 - 2012 Medical Doctor (M.D.)
Harvard Medical School, Boston, MA
2001 - 2005 Biochemistry (A.B. Magna cum laude)
Bowdoin College, Brunswick, ME

HONORS/AWARDS

2017   Ronald G. Michels Fellowship Foundation Award Winner
2017-2018   American Society of Retina Specialists Fellow in Training (FIT) Co-Chair
2016-2017   Heed Ophthalmic Foundation Fellow
2016-2017   Society of Heed Fellows
2015   Hogan/Garcia Award for best research paper by a UCSF Ophthalmology resident
2015-2016   Vice President of the Cordes UCSF Alumni Society
2014   Awarded $10,000 grant from the Patient Care Fund at SF General Hospital
2008-2012   Dr. Clinton Noyes Peters and Alice F. Peters Scholarship
2007   ARVO travel grant recipient
2005   Departmental Honors in Biochemistry, Magna cum laude
2005   Phi Beta Kappa, Alpha of Maine
2001-2005s   Sarah and James Bowdoin Scholar
2003-2004   Bowdoin Book Award (4.0 grade point average)
2003   Kamerling Laboratory Award (for excellence in organic chemistry)
Research Program
2002   Coles research fellow

PROFESSIONAL ACTIVITIES

2016-2018 Retina Fellow, Wills Eye Hospital
2014-2016 Ophthalmology Resident, UCSF
2005-2012 Research Assistant, Children’s Hospital Boston, Harvard Medical School
2005 Research Assistant, Bowdoin College
2004 Developed a computerized model to quantify vaso-obliteration
and neovascularization in retinas from mice with oxygen-induced retinopathy

 

PUBLICATIONS

Aderman CM, Rahimy E, Obeid A, Hsu J, Garg SJ, Regillo CD, Gupta OP, Chiang A. Comparing patient experience with intravitreal injections using 33‐gauge versus 30‐gauge needles. Ophthalmology Retina. In Press.
Gao X, Obeid A, Aderman CM, Ali FS, Vander JF, Hsu J, Ho AC.  Intravitreal Anti‐ Vascular Endothelial Growth Factor Injections for Macular Edema Associated with Central Retinal Vein Occlusion in Patients Under 40 Years of Age.  Journal of VitreoRetinal Disease.  In Press.
Jenkins TL, Aderman CM, Ho AC. Reversible retinal toxicity in a patient taking axitinib. AXITINIB. Retin Cases Brief Rep. 2018 Jul 13. doi: 10.1097/ICB.0000000000000771.
Obeid A, Gao X, Ali FS, Talcott KE, Aderman CM, Hyman L, Ho AC, Hsu J. Loss to Follow‐Up in Patients with Proliferative Diabetic Retinopathy after Panretinal Photocoagulation or Intravitreal Anti‐VEGF Injections. Ophthalmology. 2018 Mar 29. pii: S0161‐6420(17)33569‐8.
Aderman CM, Gorovoy IR, Chow DL, Bloomer MB, Stewart JM. Cryptococcal choroiditis in advanced AIDS: clinicopathologic correlation. Manuscript in preparation.
Aderman CM, Chao DL, Chiu CS, Bhisitkul RB. Bilateral recurrent Enterococcus faecalis endophthalmitis. Manuscript in preparation.
Aderman CM, Rivera-Sanchez L, De Alba Campomanes A. Recurrence after Lucentis for retinopathy of prematurity. Manuscript in preparation.
Aderman CM, Schwartz DM. Acute Bilateral Vision Loss. JAMA Ophthalmol. 2015 Dec 30:1-3.
Grumbine FL, Aderman C, Vagefi MR, Kersten RC. Orbital MRI Pre- and Post-Vemurafenib Therapy for ErdheimChester Disease. Ophthal Plast ReconstrSurg. 2015 Apr 16.
SanGiovanni JP, Chen J, Sapieha P, Aderman CM, Stahl A, Clemons TE, Chew EY, Smith LE. DNA sequence variants in PPARGC1A, a gene encoding a coactivator of the ω-3 LCPUFA sensing PPAR-RXR transcription complex, are associated with NV AMD and AMD-associated loci in genes of complement and VEGF signaling pathways. PLoS One. 2013;8(1):e53155.
Chen J, Stahl A, Krah NM, Seaward MR, Joyal JS, Juan AM, Hatton CJ, Aderman CM, Dennison RJ, Willett KL, Sapieha P, Smith LE. Retinal expression of Wnt-pathway mediated genes in low-density lipoprotein receptor-related protein 5 (Lrp5) knockout mice. PLoS One. 2012;7(1):e30203.
Chen J, Stahl A, Krah NM, Seaward MR, Dennison RJ, Sapieha P, Hua J, Hatton CJ, Juan AM, Aderman CM, Willett KL, Guerin KI, Mammoto A, Campbell M, Smith LE. Wnt signaling mediates pathological vascular growth in proliferative retinopathy. Circulation. 2011 Oct 25;124(17):1871-81.
Sapieha P, Stahl A, Chen J, Seaward MR, Willett KL, Krah NM, Dennison RJ, Connor KM, Aderman CM, Liclican E, Carughi A, Perelman D, Kanaoka Y, Sangiovanni JP, Gronert K, Smith LE. 5-Lipoxygenase Metabolite 4-HDHA Is a Mediator of the Antiangiogenic Effect of omega-3 Polyunsaturated Fatty Acids. Science Transl Med. 2011 Feb 9;3(69):69ra12.
Stahl A, Sapieha P, Connor KM, Sangiovanni JP, Chen J, Aderman CM, Willett KL, Krah NM, Dennison RJ, Seaward MR, Guerin KI, Hua J, Smith LE. PPAR gamma mediates a direct antiangiogenic effect of omega 3-PUFAs in proliferative retinopathy. Circ Res. 2010 Aug 20;107(4):495-500.
Stahl A, Connor KM, Sapieha P, Chen J, Dennison RJ, Krah NM, Seaward MR, Willett KL, Aderman CM, Guerin KI, Hua J, Löfqvist C, Hellström A, Smith LE.The mouse retina as an angiogenesis model. Invest Ophthalmol Vis Sci. 2010 Jun;51(6):2813-26.
Connor KM, Krah NM, Dennison RJ, Aderman CM, Chen J, Guerin KI, Sapieha P, Stahl A, Willett KL, Smith LE. Quantification of oxygen-induced retinopathy in the mouse: a model of vessel loss, vessel regrowth and pathological angiogenesis. Nature Protoc. 2009;4(11):1565-73.
Mammoto A, Connor KM, Mammoto T, Yung CW, Huh D, Aderman CM, Mostoslavsky G, Smith LE, Ingber DE. A mechanosensitive transcriptional mechanism that controls angiogenesis. Nature. 2009 Feb 26;457(7233):1103-8.
Lofqvist C, Willett KL, Aspegren O, Smith AC, Aderman CM, Connor KM, Chen J, Hellstrom A, Smith LE Quantification and localization of the IGF/insulin system expression in retinal blood vessels and neurons during oxygen-induced retinopathy in mice. Invest Ophthalmol Vis Sci. 2009 Apr;50(4):1831-7.
Chen J, Connor KM, Aderman CM, Willett KL, Aspegren OP, Smith LE. Suppression of retinal neovascularization by erythropoietin siRNA in a mouse model of proliferative retinopathy. Invest Ophthalmol Vis Sci. 2009 Mar;50(3):1329- 35.
Chen J, Connor KM, Aderman CM, Smith LE. Erythropoietin deficiency decreases vascular stability in mice. J Clin Invest. 2008 Feb;118(2):526-33.
Connor KM, SanGiovanni JP, Lofqvist C, Aderman CM, Chen J, Higuchi A, Hong S, Pravda EA, Majchrzak S, Carper D, Hellstrom A, Kang JX, Chew EY, Salem N Jr, Serhan CN, Smith LE. Increased dietary intake of omega-3- polyunsaturated fatty acids reduces pathological retinal angiogenesis. Nature Med. 2007 Jul;13(7):868-73.
Lofqvist C, Chen J, Connor KM, Smith AC, Aderman CM, Liu N, Pintar JE, Ludwig T, Hellstrom A, Smith LE. IGFBP3 suppresses retinopathy through suppression of oxygen-induced vessel loss and promotion of vascular regrowth. Proc Natl Acad Sci U S A. 2007 Jun 19;104(25):10589-94.
Linton BR, Reutershan MH, Aderman CM, Richardson EA, Brownell KR, Ashley CW, Evans CA and Miller SJ. Asymmetric Michael addition of α-nitro-ketones using catalytic peptides. Tetrahedron Lett. 2007 48:1993-7.
Banin E, Dorrell MI, Aguilar E, Ritter MR, Aderman CM, Smith ACH, Friedlander J, and Friedlander M. T2-TrpRS Inhibits Preretinal Neovascularization and Enhances Physiological Vascular Regrowth in OIR as Assessed by a New Method of Quantification. Invest. Ophthalmol. Vis. Sci. 2006 47: 2125-2134.

ABSTRACTS AND PRESENTATIONS

C.M. Aderman and A. Chiang. Intravitreal Injections with 33‐Gauge Versus 30‐Gauge Needles: Comparing Patient Experience. Wills Eye Conference. Philadelphia ,. March 8, 2018.
C.M. Aderman, N. Joshi, M.K. Adam, W. Samara, A. Shahlaee, J. Hsu, M.S. Fineman, S.J. Garg. Optical Density of Sub‐retinal Fluid in Patients with Chronic Central Serous Retinopathy Treated with Eplerenone. Retina Society. Oct 2017.
C.M. Aderman, E. Rahimy, A. Shahlaee, J. Hsu. Conversion to Aflibercept After Prior Anti‐VEGF Therapy for Persistent Diabetic Macular Edema: One Year Follow Up. ARVO Meeting Abstracts. May 2017.
C.M. Aderman.  Bilateral Serous Retinal Detachments Associated with Toxemia of Pregnancy.  Atlantic Coast Retina Conference. January 5, 2017.
C.M. Aderman, M. Deiner, M. Gupta, J. Blaha, M.H. Levin. Dichoptic virtual reality therapy for amblyopia in adults. ARVO Meeting Abstracts. June 2015 Vol 56: 2191.
C.M. Aderman. Cryptococcal choroiditis in advanced AIDS. Presentation at Pacific Retina Club Annual Meeting. Los Angeles, CA, March 2015.
C. M. Aderman, Y. Sun, Z. Shao, J.S. Joyal, L. E. H. Smith. Novel technique for sectioning a mouse retinal flat mount. ARVO Meeting Abstracts. April 30, 2014 55:407.
D. Xu, C. M. Aderman, J. Chen, A. M. Juan, C. J. Hatton, C. G. Hurst, D. T. Pei, J. S. Joyal, J. P. SanGiovanni, L. E. H. Smith. Gene Expression Analysis Of Retinas From omega-3-PUFA and omega-6-PUFA Fed Mice In Oxygen-induced Retinopathy (OIR) Model. ARVO Meeting Abstracts. March 26, 2012 53:2543.
J. P. SanGiovanni, C. M. Aderman, C. Rojas, T. E. Clemons, E. Chew, R. Uauy, D. R. Hoffman, and L. E. Smith. Integrated Systems Approach to Study the Role of Omega-3 Long-Chain Polyunsaturated Fatty Acids in Health and Disease of the Retina ARVO Meeting Abstracts April 11, 2010 51:2774.
K. M. Connor, C. M. Aderman, K. L. Willett, J. Chen, O. Aspergren, N. SALEM, Jr., J.-P. SanGiovanni, E. Y. Chew, and L. E. H. Smith. Dietary omega-3 Polyunsaturated Fatty Acids Reverse Late Stage Pathologic Retinal Neovascularization. ARVO Meeting Abstracts April 11, 2008 49:3441.
K. L. Willett, C. M. Aderman, K. M. Connor, J. Chen, O. P. Aspegren, J. P. SanGiovanni, E. Y. Chew, N. N. Salem, S. Majchrzak, and L. E. H. Smith. Dietary Intake of Omega-3 Long-Chain Polyunsaturated Fatty Acids Modulates Arachidonic Acid Cascade Enzymes and Protects Against Pathogenic Retinal Neovascularization. ARVO Meeting Abstracts April 11, 2008 49:3442.
C. M. Aderman, K. M. Connor, J. Chen, K. L. Willett, O. P. Aspegren, J. P. SanGiovanni, E. Y. Chew, N. Salem, Jr., and L. E. H. Smith. Gene Profiles of Omega-3 and Omega-6 PUFA Fed Mice With Retinopathy. ARVO Meeting Abstracts April 11, 2008 49:3447.
J. Chen, C. M. Aderman, K. M. Connor, O. P. Aspegren, K. L. Willett, and L. E. H. Smith. Intervention of Erythropoietin in Proliferative Retinopathy in Mice. ARVO Meeting Abstracts April 11, 2008 49:5439.
J. Chen, C. M. Aderman, K. M. Connor, N. Liu, A. Higuchi, and L. E. H. Smith. Erythropoietin Protects Retina From Pathological Vessel Loss and Subsequent Proliferation. ARVO Meeting Abstracts May 10, 2007 48:1963.
K. M. Connor, C. M. Aderman, J. Chen, A. Higuchi, J.-P. SanGiovanni, E. Y. Chew, D. Carper, N. N. Salem, and L. E. H. Smith. Dietary omega-3 Long-Chain Polyunsaturated Fatty Acids Protect Against Pathological Retinal Neovascularization Through Modulation of Microglial Derived TNF-alpha. ARVO Meeting Abstracts May 10, 2007 48:1965.
C. M. Aderman, K. M. Connor, J. Chen, A. Higuchi, J. P. SanGiovanni, E. Y. Chew, C. N. Serhan, N. N. Salem, Jr., and L. E. H. Smith. Bioactive omega-3 LCPUFA Derivatives, Resolvins and Neuroprotectins, Inhibit Neovascularization in Oxygen Induced Retinopathy. ARVO Meeting Abstracts May 10, 2007 48:3414.
C.M. Aderman, K.M. Connor, Z. Kachra, J. Chen, J.X. Kang, and L.E. H. Smith. Increased omega-3 / omega-6 Fatty Acid Ratio in Fat-1 Expressing Mice Protects Against Neovascularization in Oxygen Induced Retinopathy. ARVO Meeting Abstracts May 1, 2006 47:1429.
K.M. Connor, C.M. Aderman, J. Chen, Z. Kachra, N. Salem, J.-P. SanGiovanni, E. Chew, D.A. Carper, J.-Y. Tsai, and L.E. Smith. Dietary and Pharmalogic Intervention in Proliferative Retinopathy. ARVO Meeting Abstracts May 1, 2006 47:2334.
B.R. Linton, C.M. Aderman, C.A. Evans, S.J. Miller. Peptide-catalyzed asymmetric control of nitroalkane conjugate addition. American Chemical Society National Meeting, San Diego, CA, March 2005.

IMAGE CREDITS

Cover image for J Clin Invest. 2008 Feb;118(2):526-33. Confocal image of mouse retinal vasculature
Cover image for Nature Med. 2007 Jul;13(7):868-73. Confocal image of developing mouse retinal vasculature.
Cover mage for Proc Natl Acad Sci U S A. 2007 Jun 19;104(25):10589-94. Confocal image of flat-mounted mouse retina following oxygen exposure.

PROFESSIONAL MEMBERSHIPS

American Society for Retina Specialists, 2016-present
Pacific Retina Club, 2014-2016
American Academy of Ophthalmology, 2013-present
Frederick C. Cordes UCSF Alumni Society, 2013-present
New England Society for Microscopy, 2008-2012
Association for Research in Vision and Ophthalmology, 2006-present

Practice Locations:

Barnes Road Office
9555 SW Barnes Rd, Suite 201
Portland, OR 97225
Phone : (503) 227-2020

Gresham
24601 SE Stark St.
Gresham, OR 97060
Phone : (503) 255-2291

Preparing for your Visit:

Prior to Your Appointment: Please complete and print the Patient history, HIPPA and payment policy forms even if you are an established patient. Once you have completed the forms, please bring them with you on the day of your appointment. Due to privacy issues, please do not attempt to send these forms to our office via e-mail.

Please check with your insurance company(s) to verify your “vision care” coverage for routine eye examinations by calling the customer service phone number listed on your insurance card. You may also call this same number to verify “medical” benefits for medically necessary visits and procedures.

The Day of Your Appointment:
Bring your current medical insurance card(s) with you.

  • The co-pay amount listed on your insurance card will be collected at the time of your visit.
  • For charges not covered by your individual insurance plan, payment is due at the time of service. Prompt pay discounts are available on certain services. Please ask at the front desk.

As part of your examination with us today, your pupils may be dilated. With dilation, most people experience light sensitivity and difficulty with near vision (such as reading). Some individuals also have difficulty seeing in the distance. The effects of the dilation can last several hours.

Patient Forms:

Patient History

HIPAA

Payment Policy

Request an Appointment:

Or Call:

Gresham: 503 255-2291  
Barnes Rd: 503 227-2020  
 

Patient Accounts:

If you have questions about your account or insurance, please call our patient accounts representatives at: 503-344-5115.

Administration:

503-557-2020

Videos & Reviews:

REVIEW US ONLINE

1 2 3 4 5

OUR OPTICAL SHOPS

At EyeHealth Northwest, our Opticians are committed to helping you get the best pair of glasses you have ever had. Opticians are Nationally Certified by the American Board of Opticianry and participate in ongoing continue education courses to deliver the best possible care with the most advanced technology and fashion. We can take stress out of the process, making it enjoyable for you and your family.

With more than 60 years of experience in Portland, we are now driving the Portland look by designing and curating original frame collections based on our optical expertise - Bridge City Spex. We understand the importance of individuality, functionality, and quality. The Bridge City Spex Collections can be found exclusively at our eleven EyeHealth Northwest optical shops.

LEARN MORE